WF
CVS icon

Welch & Forbes’s CVS Health CVS Stock Holding History

Welch & Forbes’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Buy
15,678
+1,173
+8% +$105K 0.02% 195
2026
Q1 		$1.04M Sell
14,505
-2,698
-16% -$208K 0.01% 219
2025
Q4 		$1.37M Buy
17,203
+173
+1% +$13.6K 0.02% 205
2025
Q3 		$1.28M Sell
17,030
-5,704
-25% -$391K 0.02% 210
2025
Q2 		$1.57M Sell
22,734
-10,312
-31% -$676K 0.02% 196
2025
Q1 		$2.24M Sell
33,046
-7,133
-18% -$427K 0.03% 173
2024
Q4 		$1.8M Sell
40,179
-10,935
-21% -$613K 0.02% 191
2024
Q3 		$3.21M Sell
51,114
-1,189
-2% -$69.4K 0.04% 149
2024
Q2 		$3.02M Sell
52,303
-12,650
-19% -$791K 0.04% 152
2024
Q1 		$5.18M Sell
64,953
-47,076
-42% -$3.6M 0.07% 130
2023
Q4 		$8.85M Sell
112,029
-7,140
-6% -$508K 0.13% 101
2023
Q3 		$8.32M Sell
119,169
-7,034
-6% -$498K 0.14% 101
2023
Q2 		$8.72M Sell
126,203
-1,791
-1% -$127K 0.14% 103
2023
Q1 		$9.51M Sell
127,994
-921
-0.7% -$77.2K 0.16% 101
2022
Q4 		$12M Buy
128,915
+99
+0.1% +$9.55K 0.22% 97
2022
Q3 		$12.3M Sell
128,816
-786
-0.6% -$77.8K 0.24% 88
2022
Q2 		$12M Buy
129,602
+911
+0.7% +$88.9K 0.22% 94
2022
Q1 		$13M Buy
128,691
+12,615
+11% +$1.33M 0.21% 94
2021
Q4 		$12M Sell
116,076
-2,450
-2% -$226K 0.18% 100
2021
Q3 		$10.1M Sell
118,526
-4,995
-4% -$418K 0.17% 107
2021
Q2 		$10.3M Sell
123,521
-4,820
-4% -$395K 0.17% 106
2021
Q1 		$9.66M Buy
128,341
+1,316
+1% +$95.9K 0.18% 105
2020
Q4 		$8.68M Sell
127,025
-401
-0.3% -$26.1K 0.17% 104
2020
Q3 		$7.44M Buy
127,426
+921
+0.7% +$57.3K 0.16% 105
2020
Q2 		$8.22M Buy
126,505
+2,837
+2% +$179K 0.19% 99
2020
Q1 		$7.34M Buy
123,668
+832
+0.7% +$55.5K 0.2% 100
2019
Q4 		$9.13M Sell
122,836
-609
-0.5% -$42.8K 0.2% 103
2019
Q3 		$7.79M Sell
123,445
-6,716
-5% -$398K 0.19% 109
2019
Q2 		$7.09M Sell
130,161
-41,994
-24% -$2.26M 0.17% 111
2019
Q1 		$9.28M Sell
172,155
-28,000
-14% -$1.73M 0.23% 98
2018
Q4 		$13.1M Buy
200,155
+2,243
+1% +$167K 0.37% 76
2018
Q3 		$15.6M Sell
197,912
-16,609
-8% -$1.19M 0.37% 77
2018
Q2 		$13.8M Sell
214,521
-71,352
-25% -$4.7M 0.36% 80
2018
Q1 		$17.8M Sell
285,873
-88,119
-24% -$6.32M 0.46% 74
2017
Q4 		$27.1M Sell
373,992
-99,481
-21% -$7.23M 0.72% 45
2017
Q3 		$38.5M Sell
473,473
-3,211
-0.7% -$254K 1.01% 34
2017
Q2 		$38.4M Buy
476,684
+4,557
+1% +$360K 1.07% 28
2017
Q1 		$37.1M Sell
472,127
-4,853
-1% -$387K 1.06% 27
2016
Q4 		$37.6M Sell
476,980
-55,620
-10% -$4.5M 1.13% 27
2016
Q3 		$47.4M Sell
532,600
-3,684
-0.7% -$348K 1.64% 15
2016
Q2 		$51.3M Buy
536,284
+9,161
+2% +$913K 1.56% 15
2016
Q1 		$54.7M Buy
527,123
+6,504
+1% +$632K 1.7% 15
2015
Q4 		$50.9M Buy
520,619
+44,233
+9% +$4.33M 1.63% 17
2015
Q3 		$46M Buy
476,386
+30,639
+7% +$3.22M 1.53% 18
2015
Q2 		$46.8M Buy
445,747
+4,991
+1% +$510K 1.45% 18
2015
Q1 		$45.5M Buy
440,756
+14,519
+3% +$1.47M 1.37% 20
2014
Q4 		$41.1M Buy
426,237
+980
+0.2% +$86.3K 1.21% 23
2014
Q3 		$33.8M Buy
425,257
+7,493
+2% +$591K 1.03% 35
2014
Q2 		$31.5M Buy
417,764
+5,027
+1% +$380K 0.99% 36
2014
Q1 		$30.9M Buy
412,737
+27,898
+7% +$1.97M 0.98% 37
2013
Q4 		$27.5M Sell
384,839
-498
-0.1% -$32K 0.87% 41
2013
Q3 		$21.9M Buy
385,337
+9,871
+3% +$588K 0.74% 47
2013
Q2 		$21.5M Buy
+375,466
New +$21.8M 0.77% 50

Other funds holding CVS

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Welch & Forbes's CVS Position: Q2 2026 in Review

Welch & Forbes increased its CVS Health (CVS) stake by 8.1% in Q2 2026, buying an estimated $105K and bringing the position to 15,678 shares worth $1.62M. The position accounts for 0.02% of the portfolio, ranked #195.

Welch & Forbes first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $54.7M in Q1 2016. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Welch & Forbes held 15,678 shares of CVS Health worth $1.62M as of Q2 2026.
  • Welch & Forbes bought 1,173 CVS Health shares in Q2 2026, an estimated $105K.
  • CVS Health made up 0.02% of Welch & Forbes's portfolio in Q2 2026, its #195 holding.
  • Welch & Forbes first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Welch & Forbes's CVS Health position peaked at $54.7M in Q1 2016.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Welch & Forbes's 13F filing for Q2 2026, filed 30 Jul 2026.